Why semaglutide causes weight loss — and what that actually feels like

Semaglutide activates GLP-1 receptors in the brain's appetite centres, directly reducing hunger signals — not just slowing digestion.
Gastric emptying slows, so meals feel more filling for longer and overall calorie intake falls without deliberate restriction.
In the STEP 1 clinical trial (68 weeks, 2.4 mg weekly dose), participants lost an average of around 15% of their body weight. Source: STEP 1, New England Journal of Medicine.
Semaglutide is a prescription-only medicine; a GPhC-registered prescriber must assess suitability before any treatment starts.

Semaglutide causes weight loss by mimicking a gut hormone called GLP-1, which signals to your brain that you are full, slows the rate at which food leaves your stomach, and gradually reduces how much you want to eat in the first place. Most people find the change isn't dramatic on day one; it builds over weeks. These are prescription-only medicines, so a clinician assesses whether they are appropriate before treatment begins.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The biology behind semaglutide's effect on appetite, fullness and weight

You're not imagining it, your hunger actually changes

Picture the moment about 20 minutes into a meal when you put your fork down because you've had enough. That signal comes partly from GLP-1, a hormone released by cells in your gut when food arrives. It travels to the hypothalamus, the brain region that manages appetite, and tells it: full now, stop eating.

Semaglutide is a synthetic version of that hormone, engineered to last far longer in the body than the natural form. The natural GLP-1 molecule breaks down in minutes. Semaglutide, injected once weekly, sustains that fullness signal around the clock. People often describe the experience as simply not thinking about food as much, and if you've wondered whether that sustained signal can also affect your sleep or keep you awake at night, it's a question worth looking into. Hunger doesn't disappear, but it becomes quieter, a background note rather than a constant demand.

This matters because it explains why weight loss on semaglutide isn't about gritting your teeth through hunger. The mechanism acts upstream of willpower. For a fuller look at how this process plays out in practice, this overview of semaglutide's mechanism goes into more detail on each pathway.

Slowing the stomach: why meals feel different on treatment

The second part of the picture is gastric emptying. GLP-1 receptors sit in the gut wall as well as the brain, and activating them tells the stomach to hold its contents back a little longer before passing them into the small intestine. Food stays with you longer. A modest lunch that would previously have left you hunting the biscuit tin by 3pm can feel genuinely sufficient for hours.

This is also why nausea is the most commonly reported side effect, particularly in the early weeks of treatment. The stomach is adjusting to a new pace. The NHS medicines page for semaglutide gives a plain-English rundown of what to expect and which symptoms warrant a call to your prescriber. Most people find the GI effects settle as the body adapts, especially when meals are kept smaller and lower in fat during the first few weeks.

The combination of reduced brain-level hunger and slower gastric emptying means calorie intake falls, not because the diet is counted to the gram, but because the body's own signals are working more effectively than they were before.

What the clinical evidence shows about weight lost

The STEP 1 trial followed adults with obesity who did not have type 2 diabetes for 68 weeks. At the 2.4 mg weekly maintenance dose, participants lost an average of roughly 15% of body weight compared with around 2.4% in the placebo group. Those are averages; some people lose considerably more, others less. The evidence behind Wegovy's weight-loss outcomes discusses how results vary and what factors affect them.

It's also worth knowing that semaglutide is sold under two brand names in the UK with different licences. Wegovy is licensed for weight management. Ozempic carries a licence for type 2 diabetes. The drug is the same; the licensed use is not, and a prescriber assesses which is appropriate. If you want to understand the full picture of how semaglutide fits into weight management specifically, this page on semaglutide and weight loss covers the licensed context in detail.

Weight regain, and why treatment isn't indefinite for everyone

One thing people sometimes find surprising: when semaglutide stops, the GLP-1 receptor signal goes with it, and for many people appetite returns to its previous level. Studies following participants after they stopped treatment showed a meaningful portion of the weight came back over the following year. This isn't a failure of the person; it reflects how biological appetite regulation works.

NICE recommends Wegovy for up to two years within a specialist weight management setting. Outside that pathway, private prescribers review treatment duration as part of each clinical reassessment. At our clinical team, every repeat order goes through a fresh review, no automatic renewals, no rubber-stamping.

If cost is a factor in your thinking, this honest look at Wegovy pricing explains what legitimate private treatment actually costs and what to watch out for. For everything about the Wegovy injection itself, the Wegovy treatment page is the place to start.

Semaglutide is a prescription-only medicine. If you think it might be suitable for you, the next step is a clinical consultation. Start your free consultation with our prescribers, a real clinician reads your answers the same day.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions